| Literature DB >> 32015753 |
Yang Zheng1, Xiangdong Duan2, Shangfeng Qi2, Haibo Hu3, Mengran Wang1, Conglin Ren1, Haipeng Xu1, Renfu Quan4.
Abstract
OBJECTIVE: This meta-analysis aimed to investigate the effectiveness of acupuncture therapy plus hyaluronic acid injection versus hyaluronic acid injection alone for patients with knee osteoarthritis.Entities:
Year: 2020 PMID: 32015753 PMCID: PMC6982364 DOI: 10.1155/2020/4034105
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow chart for the studies' screening process.
Features of the included studies.
| First author (year) | Sample size | Sex (M : F) | Age (year) (mean ± SD) | Duration (mean ± SD)(or range) | Intervention (combination therapy) | Control group (HA alone) | Outcome measures | Follow-up |
|---|---|---|---|---|---|---|---|---|
| Chen Y. (2015) | 116 | T: 26 : 32 C: 28 : 30 | T: 56.1 ± 4.8 | T: 3.7 ± 2.0 y | AT + HA 1 time per week (4 weeks) | 2 ml 1 time per week (4 weeks) | LKSS, VAS, ER | 1 year |
| Gao Y. (2017) | 80 | T: 30 : 10 | T: 59.2 ± 3.3 | T: 6.5 ± 0.5 y | WA + HA 1 time per day (15 min, 5 weeks) | 2.5 ml 1 time per week (5 weeks) | WOMAC, QOL, VAS, LKSS | 5 weeks |
| Han D. (2016) | 128 | T: 34 : 3 | T:62.4 ± 6.8 | T: 5.83 ± 0.4 y | WA + HA 3 times per week (30 min, 4 weeks) | 2 ml 1 time per week (4 weeks) | LKSS, ER | 4 weeks |
| Hao Y. F. (2017) | 80 | T: 17 : 23 | T: 55.91 ± 6.32 | T: 52.32 ± 46.5 d | MA + HA 1 time per day (30 min, 5 weeks) | 2 ml 1 time per week (5 weeks) | VAS, SF-36, ER, WOMAC | 5 weeks |
| He H. J. (2016) | 108 | T: 12 : 44 | T:50.32 ± 14.38 | T: 4 m–10 y | AT + HA 1 time per week (2 weeks) | 3 ml 1 time per week (5 weeks) | HSS, VAS | 3 months |
| Lv L. (2017) | 66 | I: 16 : 17 | I: 44.10 ± 0.18 | NM | MA + HA 5 times per week (30 min, 4 weeks) | 2 ml 1 time per week (4 weeks) | ER, VAS, HSS | 1 month |
| Ren J. (2012) | 100 | I: 24 : 26 | NM | NM | WA + HA 3 times per week (4 weeks) | 2 ml 1 time per week (4 weeks) | VAS, LKSS, ER | 1 month |
| Ren X. G. (2015) | 60 | T: 11 : 19 | T: 63.8 ± 9.8 | T: 3.4 ± 1.4 y | AT + HA 1 time every 2 weeks (4 weeks) | 2 ml 1 time per week (4 weeks) | LKSS, ER | 6 months |
| Tian H. J. (2018) | 140 | T: 34 : 36 | T: 59.5 ± 17.5 | NM | WA + HA NM | 2 ml 1 time per week (4 weeks) | LKSS, QOL | 1 month |
| Zhao Z. C. (2018) | 120 | T: 35 : 25 | T: 62.06 ± 4.37 | T: 6.50 ± 3.04 y | MA + AT + HA 7 times per week (30 min, 4 weeks) | 2 ml 1 time per week (4 weeks) | LKSS, VAS, JOA, ER | 6 months |
AT: acupotomy; WA: warm acupuncture; MA: manual acupuncture; NM: not mentioned; LKSS: Lysholm scores; VAS: visual analogue scale; ER: clinical efficacy rate; SF-36: Medical Outcomes Study 36-Item Short Form Health Survey; WOMAC: The Western Ontario and McMaster Universities Osteoarthritis Index; QOL: the scales of quality of life; JOA: the scales of Japanese Orthopedics Association; HSS: hospital for special surgery.
Figure 2Risk of bias.
Figure 3Risk of bias summary.
Figure 4Forest plot of combination group versus control group: Lysholm scores (LKSS).
Figure 5Forest plot of combination group versus control group: visual analogue scale (VAS).
Figure 6Forest plot of combination group versus control group: efficacy rate (ER).
The quality of evidence.
| Outcomes | Effect | Number of participants (studies) | Quality of the evidence (GRADE) | |
|---|---|---|---|---|
| Relative effect (95% CI) | Absolute effect (95% CI) | |||
| LKSS | — | MD 8.67 higher (6.59 to 10.75 higher) | 744 (7 studies) | ⊕⊕⊝⊝ low1,3 |
| VAS | — | MD 1.39 lower (1.99 to 0.79 lower) | 670 (7 studies) | ⊕⊝⊝⊝ very low1,2,3 |
| ER | RR 1.23 (1.15 to 1.31) | 173 more per 1000 (from 113 more to 233 more) | 750 (8 studies) | ⊕⊕⊝⊝ low1,2 |
1High risk of performance bias; one of the studies describe the allocation concealment. 2Adverse events were not sufficiently reported. 3Significant heterogeneity.